Related Experiment Video

Updated: Nov 26, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.7K

How I Treat Non-Small Cell Lung Cancer Refractory to Immunotherapy

Selina K Wong1, Leora Horn

  • 1From the Vanderbilt Ingram Cancer Center, Nashville, TN.

Cancer Journal (Sudbury, Mass.)
|December 10, 2020
PubMed

Insights

Lung cancer patients often resist immunotherapy, requiring new treatment strategies. Research explores alternative therapies like radioimmunotherapy and immunotherapy re-challenge for refractory non-small cell lung cancer.

Area of Science:

  • Oncology
  • Immunotherapy research
  • Non-small cell lung cancer treatment

Background:

  • Lung cancer remains a major cause of cancer mortality globally.
  • Immune checkpoint inhibitors have transformed advanced non-small cell lung cancer (NSCLC) treatment.
  • Primary or acquired resistance to immunotherapy is a significant clinical challenge in NSCLC.

Purpose of the Study:

  • To highlight the critical need for understanding novel response patterns to immunotherapy in NSCLC.
  • To inform the selection and sequencing of treatments for patients with resistant disease.
  • To review emerging therapeutic strategies for immunotherapy-refractory NSCLC.

Main Methods:

  • Review of current literature on immunotherapy resistance in NSCLC.
  • Analysis of ongoing clinical trials exploring alternative treatment modalities.
  • Synthesis of data on combination radioimmunotherapy and immunotherapy rechallenging.

Main Results:

  • A significant proportion of NSCLC patients exhibit resistance to immune checkpoint inhibitors.
  • Chemotherapy is the current standard for refractory cases, but its limitations are recognized.
  • Novel approaches including radioimmunotherapy and immunotherapy re-challenge are under active investigation.

Conclusions:

  • Understanding resistance mechanisms is key to optimizing NSCLC treatment.
  • Combination therapies and sequential treatment strategies show promise for refractory NSCLC.
  • Further research is essential to improve outcomes for patients with advanced NSCLC.

More Related Videos

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

17.7K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
888
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
665
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.2K